Do Hormones Fluctuate on Birth Control?

Hormones do fluctuate on birth control, though the pattern looks very different from the natural menstrual cycle. For decades, the working assumption was that combined oral contraceptive pills held both synthetic and natural hormone levels essentially flat throughout the month. Recent research has overturned that idea. A 2024 study using sensitive hormone-measurement techniques found that both the synthetic estrogen delivered by the pill and the body’s own estradiol shifted meaningfully across the 28-day pill pack, with some of the biggest swings occurring during the placebo week.

What Combined Pills Do to Your Natural Hormones

Combined oral contraceptive pills contain a synthetic estrogen (usually ethinyl estradiol) and a synthetic progestin. Together, these suppress the brain’s signals that normally trigger egg development and ovulation. The result is that your body’s own production of estradiol and progesterone drops considerably compared to a natural cycle. Studies going back to the 1970s showed that estradiol levels in women taking combined pills typically settle around 20 to 30 picograms per milliliter, roughly equivalent to the lowest point of a natural cycle and far below the peaks that occur around ovulation in unmedicated women.¹ Other hormones are affected too: luteinizing hormone, sex-hormone-binding globulin (SHBG), and progesterone all show altered profiles in pill users compared with naturally cycling women.²

So the pill doesn’t eliminate hormonal variation. It replaces the large, wave-like rises and falls of a natural cycle with a different, lower-amplitude pattern. Think of it less as flattening the landscape and more as replacing rolling hills with smaller bumps on a lower plateau.

Fluctuations Across the Pill Pack

The assumption that synthetic hormone levels stay constant from the first active pill to the last turns out to be wrong. A 2024 study that measured both synthetic and natural hormones at multiple time points throughout a monophasic pill cycle found a clear pattern of change. Ethinyl estradiol, the synthetic estrogen in the pill, was significantly higher on the twentieth and twenty-first days of active pill use than on the first and second days. Meanwhile, the body’s own estradiol moved in the opposite direction, declining during the active pill phase. Progesterone and the synthetic progestin stayed comparatively stable across the active days.³

Why would the synthetic estrogen build up over three weeks if you’re taking the same dose each day? The likely explanation involves how the body processes and clears the drug. Ethinyl estradiol is metabolized by the liver, and the speed of that metabolism can vary from person to person and even across the cycle. Over consecutive days of dosing, a small accumulation effect appears. This is a subtlety that older measurement methods probably missed, which is why the “everything is flat” narrative persisted for so long. The 2024 study used liquid chromatography with tandem mass spectrometry, a far more sensitive technique than the assays available in earlier decades.

What Happens During the Placebo Week

The most dramatic hormonal shift on the pill happens when you switch from active pills to the placebo (or sugar pill) days. Without incoming synthetic estrogen, ethinyl estradiol levels drop. At the same time, the body’s own estradiol rebounds sharply. The same 2024 study found that natural estradiol levels on days 27 and 28 of the pack were significantly higher than they had been during the middle and late active-pill phase.³ This makes physiological sense: once the suppressive effect of the synthetic hormones eases, the ovaries begin to wake up, and estradiol production ticks upward before the next pack’s active pills push it back down.

This placebo-week surge is what triggers withdrawal bleeding, which mimics a period but is not a true menstrual period driven by ovulation. It also explains why some people feel noticeably different during those final days of the pack: headaches, mood shifts, and breast tenderness during the hormone-free interval likely track this rapid swing in both synthetic and natural hormone levels. If you’ve ever thought that you can “feel” the placebo week, the hormonal data suggests you probably can.

Extended and Continuous Regimens

The traditional pill pack follows a 21-days-on, 7-days-off pattern. But over the past couple of decades, newer regimens have shortened or eliminated the placebo interval entirely. Some packs provide 24 active pills and only 4 inactive days, while extended-cycle options offer 84 consecutive active days followed by 7 days off. Continuous regimens skip the break altogether.⁴

The hormonal logic here is straightforward: by eliminating or shortening the hormone-free window, you avoid the placebo-week estradiol rebound described above. That means fewer dramatic swings and, for many people, fewer of the symptoms tied to those swings. Continuous users still have fluctuations in synthetic hormone levels over time (the same accumulation effect applies), but they skip the largest single hormonal shift the pill creates. This is one reason providers sometimes recommend skipping the placebo week for patients who get migraines or severe mood changes at the end of each pack.

How the Pill Changes Testosterone

One of the most consistent hormonal effects of combined pills rarely gets discussed outside a clinical setting: the substantial drop in circulating testosterone. A systematic review and meta-analysis covering data from many studies found that total testosterone fell significantly during combined pill use, and free testosterone dropped by an average of about 61 percent. At the same time, SHBG, a protein that binds to sex hormones and reduces the amount available to tissues, roughly doubled.⁵

This shift happens across all types of combined pills, though the magnitude varies depending on which progestin the formulation contains. The clinical implications are real. Lower free testosterone is part of why the pill helps with hormonal acne and excess hair growth, but it may also contribute to decreased libido or changes in energy levels that some users report. The SHBG increase is particularly stubborn: some research suggests it doesn’t fully return to baseline immediately after stopping the pill, which has fueled debate about whether long-term pill use can have lasting effects on androgen balance.

Progestin-Only Pills

Progestin-only pills (sometimes called the minipill) work differently from combined pills. Most older formulations contain a low dose of a single progestin with no synthetic estrogen. Because there is no estrogen component suppressing the hypothalamic-pituitary-ovarian axis from both angles, the body’s own estrogen production is less thoroughly clamped down. Ovulation is suppressed inconsistently: the primary mechanism is thickening cervical mucus and thinning the uterine lining, rather than preventing ovulation outright.

This means that on a progestin-only pill, your natural estrogen and progesterone cycles can partially persist. The hormonal picture is noisier and less predictable than on a combined pill. A randomized crossover study of a norgestrel progestin-only pill found that about 30 percent of participants ovulated when pill-taking was deliberately disrupted, confirming that suppression of ovulation is incomplete even under ideal conditions.⁶ This partial suppression is why some people on progestin-only pills still notice cyclic mood or physical changes that feel like a muted version of their natural cycle.

Hormonal IUDs and Implants

Hormonal IUDs, such as those releasing levonorgestrel, deliver progestin locally to the uterus. The amount that reaches the bloodstream is lower than with oral pills or implants. Plasma levels of levonorgestrel from an IUD typically stabilize at around 150 to 200 picograms per milliliter within the first few weeks after insertion.⁷ Because systemic hormone levels are comparatively low, ovulation frequently continues in IUD users. That means your body’s own estrogen and progesterone may follow something closer to a natural cyclical pattern, with the IUD working primarily through local effects on the uterine lining and cervical mucus.

For some people, this is a meaningful advantage: they get reliable contraception without the degree of systemic hormonal suppression that comes with the pill. But it also means that IUD users can still experience cyclical hormonal fluctuations, including premenstrual symptoms, even if they no longer bleed regularly. The reduced bleeding that many IUD users enjoy is mostly a local uterine effect, not a sign that hormonal cycles have stopped.

The Injectable (Depo-Provera)

Depot medroxyprogesterone acetate (DMPA), commonly known as Depo-Provera, takes a different approach. A single injection delivers a large dose of a progestin that slowly releases over roughly 12 weeks. The hormonal profile after injection shows a spike in medroxyprogesterone acetate that gradually tapers. One study found that estradiol levels, even after very long-term use of the injectable, remained within the normal range for the early follicular phase of a natural cycle, and that gonadotropins (the brain hormones that drive ovarian function) stayed within normal ranges as well. The drug did not accumulate in the blood between injections, and the changes in estradiol, progestin, and SHBG after each shot disappeared within 12 weeks.⁸

So the injectable creates its own kind of fluctuation: a sawtooth pattern where progestin levels peak after the shot and gradually decline until the next one. In the weeks just before the next injection is due, progestin levels are at their lowest, and some users notice a return of symptoms like spotting or mood changes. This is less a steady state than a slow wave timed to the injection schedule.

What Happens When You Miss a Dose

Missed pills are one of the fastest ways to introduce unplanned hormonal fluctuation. A systematic review of missed-dose studies found that extending the hormone-free interval to 8 to 14 days produced a wide range of follicular development among women, meaning the ovaries started gearing up to release an egg in some users but not others. Missing one to four consecutive pills at other points in the pack generally produced less follicular activity and a low risk of ovulation.⁹

The timing matters more than the number. Missing pills right before or right after the placebo week effectively lengthens the hormone-free interval, which is when the body is already primed to rebound. Missing a pill mid-pack, while not ideal, has less impact because the synthetic hormones haven’t fully cleared. The review also found that lower-dose pills (those with 20 micrograms of ethinyl estradiol) showed more follicular activity after missed doses than higher-dose pills (30 micrograms), suggesting that the margin for error shrinks as the estrogen dose goes down.⁹

From a hormonal-fluctuation standpoint, a missed dose is essentially a mini hormone-free interval. Your body senses the sudden absence of synthetic hormones and begins its rebound process. If you’ve ever felt a little “off” after forgetting a pill, the abrupt dip in exogenous hormone levels is the likely culprit.

Body Weight, Genetics, and Individual Variation

Not everyone processes contraceptive hormones at the same rate. Body weight is one factor that has received attention: some studies have found that higher body weight is associated with altered pharmacokinetics for combined pills, the contraceptive patch, and emergency contraception, potentially reducing their effectiveness.¹⁰ In practical terms, a person with a higher body mass may clear the synthetic hormones faster or distribute them into a larger volume of tissue, meaning blood levels could be lower and more variable than in someone of average weight taking the same pill.

Genetics adds another layer. A growing field of research is exploring how specific genetic variations in liver enzymes and hormone receptors affect how individuals metabolize contraceptive steroids. A 2025 narrative review summarized what is currently known about pharmacogenetic interactions with hormonal contraceptives and the polymorphisms suspected to contribute to side effects and differences in outcomes.¹¹ This research is still in its early stages, but the underlying concept is intuitive: if your liver metabolizes ethinyl estradiol unusually fast, you effectively get a lower dose from the same pill, and your hormone levels will dip further between doses.

These individual differences help explain why two people on the exact same pill can have very different experiences. One person feels hormonally stable and side-effect-free; another feels like they’re on an emotional roller coaster. The pill delivers a fixed dose, but what happens after it enters your body depends on your metabolism, your weight, your genetics, and even what other medications you’re taking. The hormonal “flatness” that birth control is supposed to provide is more of an average across a population than a guarantee for any individual.

Why “Stable Hormones” Became the Default Narrative

For years, patient education materials described combined pills as providing stable, predictable hormone levels throughout the active phase. This narrative wasn’t fabricated out of thin air. Older measurement techniques were less sensitive than modern ones, and small fluctuations that are now detectable simply didn’t show up. The 2024 study that documented within-cycle variation in ethinyl estradiol explicitly noted that its findings “challenge the previous assumption that endogenous and exogenous hormones are stable throughout the 28-day pill cycle.”³

The practical takeaway is that if you notice subtle changes in how you feel at different points in your pill pack, you’re not imagining things. The hormonal environment inside your body is genuinely shifting, just on a smaller scale than a natural cycle. The conventional framing of “the pill keeps your hormones steady” was always an oversimplification. It would be more accurate to say the pill narrows the range of fluctuation and replaces the dramatic peaks and valleys of a natural cycle with gentler, less predictable undulations. Whether those smaller fluctuations bother you depends on your individual sensitivity, your specific formulation, and how consistently you take it.

Triphasic and Multiphasic Formulations

Most of the research described so far focuses on monophasic pills, which deliver the same dose of synthetic hormones in every active pill. But triphasic and biphasic formulations exist specifically to vary the dose across the cycle, usually stepping up the progestin component and sometimes adjusting the estrogen dose as well. The intention behind these designs was to mimic the natural cycle’s shifting ratios more closely, on the theory that this might reduce side effects like breakthrough bleeding.

In practice, the evidence that multiphasic pills produce fewer side effects than monophasic ones is thin. What they do produce is a more complex hormonal profile by design: you’re deliberately introducing planned fluctuations in synthetic hormone levels on top of whatever variation your body creates on its own. If you’re on a triphasic pill and you notice that you feel different in the third week compared to the first, the changing dose is an obvious candidate. For people who are sensitive to hormonal shifts, a monophasic pill may actually provide a more even ride, despite the within-cycle variation the 2024 study identified. Switching from one pill type to another is one of the more concrete tools available for managing hormone-related side effects.